Diamond Medical Laboratories, LLC.

Diamond Medical Laboratories, LLC. was paid $2.24M by Medicaid between Jan 2018 and Nov 2024, across 75 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 36% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Maryland

Rank by total paid#28 of 93

Median peer was paid$430K

This provider vs. median5.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	11,237	$16K
2019	25,410	$41K
2020	37,805	$313K
2021	50,902	$566K
2022	93,015	$410K
2023	89,788	$408K
2024incomplete	95,018	$491K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	36%	13,404	4,948	$813K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	10%	48,530	29,643	$229K
80053	Comprehensive metabolic panel	9.3%	37,246	26,428	$209K
80048	Basic metabolic panel (calcium, ionized)	7.5%	32,853	16,788	$169K
36415	Collection of venous blood by venipuncture	6.9%	65,029	29,981	$156K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	5.6%	9,156	7,801	$127K
80061	Lipid panel	3.5%	13,916	12,186	$78K
84443	Thyroid stimulating hormone (TSH)	3.4%	8,147	6,588	$77K
83036	Hemoglobin; glycosylated (A1C)	3.2%	14,958	12,565	$71K
85027		1.7%	11,874	8,448	$38K
80164		1.0%	2,839	2,246	$23K
83735		<1%	4,171	2,903	$19K

63 more codes

82140		<1%	2,167	$18K
80202		<1%	1,732	$16K
80177		<1%	1,967	$15K
85610		<1%	6,819	$15K
82607		<1%	1,665	$14K
86140		<1%	3,443	$12K
83880		<1%	505	$11K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	8,712	$11K
84439		<1%	1,821	$8K
81001		<1%	6,603	$8K
82728		<1%	919	$7K
83970		<1%	283	$7K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	141	$7K
85652		<1%	3,241	$7K
82746		<1%	700	$6K
80076		<1%	1,487	$6K
84132		<1%	2,376	$6K
84100		<1%	1,494	$5K
G0471	Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha)	<1%	33,626	$5K
P9603	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled	<1%	45,010	$4K
83540		<1%	1,060	$4K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	278	$4K
87631		<1%	47	$4K
85730		<1%	867	$3K
84153		<1%	456	$3K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	42	$3K
84480		<1%	304	$2K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	71	$2K
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	<1%	7,560	$2K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	125	$1K
87581		<1%	165	$1K
87481		<1%	136	$1K
85018		<1%	788	$1K
85014		<1%	788	$1K
84436		<1%	322	$1K
84550		<1%	391	$946.12
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	16	$821.28
84134		<1%	65	$806.13
87500		<1%	144	$774.48
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	27	$757.79
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	75	$667.29
87493		<1%	104	$657.35
87556		<1%	119	$633.46
80185		<1%	122	$596.03
85045		<1%	388	$578.74
87486		<1%	118	$533.33
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	124	$533.33
87541		<1%	119	$533.33
87496		<1%	118	$533.33
87640		<1%	125	$533.33
87498		<1%	125	$533.33
87561		<1%	119	$533.33
87641		<1%	124	$533.33
87653		<1%	125	$533.33
83550		<1%	164	$479.40
87503		<1%	131	$444.22
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	18	$411.68
82248		<1%	230	$394.74
82550		<1%	43	$235.50
87086	Culture, bacterial; quantitative colony count, urine	<1%	46	$188.82
87088		<1%	17	$72.13
82040		<1%	12	$46.80
0112U		0%	123	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKLUTTZ, ALLEN (CEO)